Get started

Upside

$QBIO is our New Low-float, BioTech Alert w/ MASSIVE UPSIDE!===================== QBIO (Q BioMed Inc.) Alert Price: $1.77 Float: 9.2M Investor Presentation Fact Sheet Shareholder Update Corporate Update Video ======================== Members, We hope you enjoyed the over +23% in realistic profit that Wednesday's alert provided. Earlier today, we told you that we had identified a company operating in the biotech space that looks primed and ready to breakout for some significant gains in the immediate future. Please turn your immediate attention to QBIO (Q BioMed Inc.). This biomedical acceleration and development company appears to be extremely undervalued and oversold at the moment, and we want our members to be on board for what we believe will be an epic bullish reversal in Q1 2019. The company has several bullish catalysts working in its favor that we believe will help make it a significant winner for our members: The biotech sector as a whole has been on fire, and is up over +20% since December 24th. Strong corporate leadership led by CEO Denis Coran. A growing pipeline and strategy that mitigates risk & drives shareholder value. Acquired the metastatic skeletal cancer palliation drug, Metastron™, from GE Healthcare.The agreement gives QBIO ownership of the brand, trademarks and market authorizations in 22 countries. In addition, all historical and current sales and distribution data related to those market authorisations will be assigned or transferred to QBIO to allow for as seamless a transition as possible in all markets. QBIO anticipates Metastron™ to start generating revenue in 1H 2019, with gross palliation revenue expected to be $20M-$40m p/a in year 3. QBIO's QBM-001 treatment for pediatric non-verbal disorder has $5B in global market potential. QBIO believes that it will complete formulation and manufacturing of QBM-001 by the end of the second quarter of 2019, after which it will file an investigational new drug (IND) application with the FDA. The company is hopeful that QBM-001 may receive the relevant designations from the FDA that could accelerate the development timeline. Assuming authorization from the FDA for the IND, the company believes it could begin a pivotal clinical trial of QBM-001 in the third quarter of 2019, which could lead to reviewed interim data as early as the first quarter of 2020. Now what has us really excited about QBIO, is what we heard during CEO Denis Coran's audio interview with SmallCapVoice.com on January 15th. At around the twelve minute mark, Mr. Coran hints at an upcoming FDA approval for QBIO's south Texas manufacturing facility. Once approved QBIO can start producing Metastron™ commercially for sale in the U.S. and then internationally! This drug is a substantial opportunity for QBIO. A very similar drug with a very narrow indication currently does almost $800 million a year in revenue! This would be huge news, and could have a major impact on QBIO's stock price. This is a great and informative interview, and it should get you excited about the incredible opportunity that QBIO presents you at the moment. We would also like to mention, that just like several of our past big winners, QBIO trades on the OTCQB Venture Marketplace. Securities trading on OTCQB have higher reporting and certification standards, which tends to lead to increased liquidity, investor confidence, as well as enhanced shareholder value. This has the potential to be our next big winner of Q1 2019. As such, we are urging all members to read our full profile, start their research now, and consider grabbing up a position in QBIO tomorrow morning at 9:30AM EST! About Q BioMed Q BioMed, Inc. is a biomedical acceleration and development company. They are focused on licensing and acquiring biomedical assets across the healthcare spectrum. Q BioMed is dedicated to providing these target assets the strategic resources, developmental support and expansion capital they need to meet their developmental potential so that they can provide products to patients in need. QBIO approaches biopharmaceutical development from a nontraditional angle. Rather than strictly devoting its resources to internal development, the company licenses what it deems to be undervalued biomedical assets in order to accelerate the achievement of clinical and commercial milestones. The company has five assets in its pipeline, led by its cancer palliation program, and diversified across multiple areas of significant medical need, including developmental nonverbal disorder, liver cancer and glaucoma. Q BioMed Unlocks Undiscovered Biomedical Value Targets assets entering validation, clinical stages or commercialization leading up to value creating inflection points Deploys performance-based capital and resources to accelerate the development of an asset milestone achievement by its management Licenses or acquires the assets and works together to create valuation growth How Q BioMed Accelerates Biomedical Technology Development Unlocks capital in US public markets to fund the development of assets Makes liquid investments in high-value assets that can produce exponential returns Diversifies risk over several therapies in various stages of development and deploys performance-based capital only Accelerates its asset’s development with management and advisory teams' expertise, experience, and industry relationships Recent Developments Q BioMed Adds Clinical Psychologist at Yale's Child Study Center, Dr. Pamela Ventola to Advisory Committee for QBM-001 On Wednesday, QBIO announced that Pamela Ventola Phd, from Yale University has joined its Advisory Committee for its QBM-001 clinical program. QBM-001 is being developed and tested for the treatment of minimally verbal or non-verbal toddlers with an Autism Spectrum Disorder (ASD). Dr. Ventola serves as a clinical psychologist and assistant professor at Yale University's Child Study Center with a clinical and research focus in: behavioral treatment for autism spectrum disorders, Pivotal Response Treatment (PRT), biological markers of treatment response, and dissemination and implementation of treatment for ASD. Dr. Ventola also directs the Rare Disease and Pediatric Center of Excellence at Cogstate, a publicly traded company that supports pharmaceutical companies in clinical trial design, methodologies, and rater training services as it relates to cognitive and other clinical outcome assessments. Strategy and Clinical Trial Design Specialist Provides Expertise for the Clinical Trial Design and Regulatory Requirements of QBM-001 QBM-001 Developed to Treat a Pediatric Non-Verbal Disorder which impacts 18,000 children each year in the U.S and a similar amount in Europe. Market Outlook The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022. Bone Metatases from Prostate and Breast Cancer 450,000 new breast and prostate cancer diagnoses each year 1 in 3 people will develop bone metastases from the spread of breast and prostate cancer Pediatric Non-Verbal Disorder Among the >60,000 US children who develop Autism Spectrum Disorders (ASD) every year, 20,000 become nonverbal and will have to rely on assisted living for the rest of their life. Liver Cancer 700,000 patients worldwide Short 1-year survival rate Estimated 39,230 adults in the US will be diagnosed every year Glaucoma 60 million patients worldwide 8 million with bilateral blindness Typically no early warning signs Therapy only slows progression, no cure Technical Analysis QBIO's stock price has been on a downtrend as of late, but we believe that the bottom is in, and that the upside potential far outweighs the downside risk. CEO Denis Coran addressed the stocks decline in his most recent shareholder update, and we feel confident that he and his management team are well on their way towards reversing this downtrend. QBIO is trading well off its 52-week high, with plenty of room to the upside. In fact, a run back to its 52-week high of $4.50 would represent a gain of over +154%! The float on QBIO is also very thin at just $1.77, so don't be surprised if we see a big move from this ticker tomorrow. As we stated above, this could easily be our next big winner of Q1 2019. We are urging all members to start their research now, and consider grabbing up a position in QBIO tomorrow morning at 9:30AM EST! (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by Awareness Consulting Network to conduct investor relations advertising and marketing for QBIO. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
OTC:QBIOLong
by RedHotStocks
EurUsdPrice has been ranging within a 200/250 pip range since mid October. Price broke out of the key 1.1500 area which has acted as major resistance for a while. Price broke this 1.1500 zone with a very bullish candle, a retest has occurred of the zone and I see more upside potential with this pair. I would like to see the next upside target of 1.1600 in the short term, and then I believe price has the potential again to move even higher to test the 1.1800 handle in the short/medium term.
Long
by mattmach
EDNT has Up To +44pct in UPSIDE POTENTIAL in the Near-Term!===================== Our New Pick is: EDNT Current Price: $6.25 Float: 825.59K Corporate Update/Investor Presentation ======================== Members, One of our favorite low-float, Nasdaq listed alerts appears to be primed and ready for another round of +20% single-day gains. Please turn your immediate attention EDNT (Edison Nation Inc.). We first brought EDNT to your attention back on October 30th. Members who acted on our buy call were able to secure up to +23.95% in realistic gains. We are now anticipating another big move from EDNT. Here's why... EDNT is coming off one of their most impressive quarters history. The Company witnessed a huge increase in both their top and bottom line. Revenue in the third quarter of 2018 increased 56% to $4.9 million, compared to $3.2 million in the third quarter of 2017. Gross profit increased 26% to $1.3 million in the third quarter of 2018, compared to $1.0 million in the third quarter of 2017. Despite these blockbuster numbers, EDNT has managed to fly under the radar. But we have a strong feeling that this will all change tomorrow. Once the Street takes notice of EDNT's dynamite Q3, this low-float ticker could blow past $7.00 and possibly hit a new 52-week high. That's right, the float on EDNT is just 825.59k. A float that low is almost unheard of for a Nasdaq listed company. As you all know, we love these low-float picks. The slightest burst in volume can shares soaring. And if they go viral, traders could see single-day gains of over +100%! Immediate Bullish Catalysts for EDNT: Low-float of just 825.59k Acquired Cloud b, Inc., the world’s leading manufacturer of products and accessories that help parents and children sleep better. Launched its first micro-brand crowdfunding campaign on Kickstarter, the MasterSous: The 8-in-1 Smart Cooker. Growing revenue (Q/Q) Q3 2018 Revenues Increase 56% to $4.9 Million; Gross Profit Increases 26% to $1.3 Million $6.5M in gross proceeds from April 2018 IPO Partners with several Fortune 500 companies such as, Walmart, Target, Rite-Aid, Disney, Home Depot, and Amazon High insider ownership (47%) About Edison Nation Edison Nation, Inc. is a vertically integrated innovation aggregation and full-service product development and manufacturing company, offering innovation sourcing, design, sales, fulfillment and shipping services. Edison Nation's model is to provide a risk mitigated platform that connects innovators with companies to bring new products to market. Company Highlights Edison Nation, Inc. (Edison Nation) is a vertically integrated, full-service, product development and manufacturing company (design, manufacture, sales & fulfillment) Edison Nation’s business provides a low-cost R&D platform to test consumer interest in new products via innovation searches, disintermediating the traditional high fixed-cost R&D model (average cost to develop and test a product is $25,000) Their successfully licensed products on behalf of their inventors have generated +$250M in sales Completed Reg A+ IPO of common stock and listed on NASDAQ in May 2018, raising $6.5M in gross proceeds at $5.00/share. Experienced leadership team with high insider ownership (~47%) What does Edison Nation Do? Since inception, Edison Nation has invested ~$11M to create a propriety open innovation platform, allowing inventors to safely and securely submit their ideas to be evaluated for various commercialization paths from licensing to, most recently, crowd funding. Typical crowd funding product development cycle: Edison Nation’s team of product designers and engineers then produce a ready for production prototype, and produce media in-house to launch a crowd funding campaign. If a campaign is successful they will market the product in the “aftermarket” on sites such as Amazon & Jet Products are generally manufactured in China with factories (we have 10+ year relationships, generally shipping within 4-6 weeks from order) Growth Opportunities: Utilizing the Edison Nation platform to organically source innovative ideas, bringing them to market through their low-risk crowd funding strategy (strong engine for future ideas to bring to market) Continued growth of licensed product manufacturing through Fortune 500 partners such as Disney, Marvel, and Universal Studios Acquisition of promising products/micro-brands using a combination of cash and stock Recent Developments Edison Nation, Inc. Provides Third Quarter 2018 Corporate Update and Financial Results Q3 2018 Revenues Increase 56% to $4.9 Million; Gross Profit Increases 26% to $1.3 Million Recent Operational Highlights: Acquired the Company’s strategic partner, Edison Nation LLC, the leader in crowdsourced innovation, which enables the Company to fully leverage its established operating infrastructure to form a true full-service product development platform. Changed the Company’s corporate name to Edison Nation, Inc. In conjunction with the name change, the Company’s ticker symbol changed from “XSPL” to “EDNT” on the Nasdaq. Acquired Cloud b, Inc., the world’s leading manufacturer of products and accessories that help parents and children sleep better, whose products are distributed in over 100 countries worldwide. As a private company, the unaudited estimate for revenue from Cloud b in 2017 was approximately $8.0 million for 2017 with a gross margin of 45%. The acquisition is expected to be immediately accretive to Edison Nation. Launched the Company’s first micro-brand crowdfunding campaign on Kickstarter, the MasterSous: The 8-in-1 Smart Cooker. To-date, the Kickstarter campaign has exceeded the initial pledged goal by more than 300%. Engaged with Church and Dwight, BLACK + DECKER and Worthington Industries to launch innovative searches in product categories of each company’s respective area of interest, aggregating relevant submissions through the Company’s Edison Nation platform. Launched a new Crowdfunding tool by which the Company will cover development and crowdfunding campaign-related costs for select, high-potential ideas, allowing products to reach the market at lightening-speed to maximize sales and reduce total R&D costs. Management Commentary “The momentum we established in the first half of the year has continued, highlighted by our revenue growth of 56% to a record $4.9 million in the third quarter of 2018,” said Chris Ferguson, Chief Executive Officer of Edison Nation. “In addition to this growth, we’ve made significant strides to accelerate growth moving forward, most notably with our successful acquisition of our strategic partner, Edison Nation, LLC, the leader in crowdsourced innovation, which will enable us to fully leverage our established operating infrastructure to form a true full-service product development platform. This acquisition will serve as our engine for product innovation and provide a strong pipeline of micro-brand opportunities for us to leverage, as we are able identify proprietary products through idea submission, find the ‘best of the best’, and launch them into the market quickly. We will do this either through licensing agreements with our established base of relationships, or via our newly announced crowdfunding strategy–a de-risked business model that allows us to generate initial sales on platforms such as Kickstarter and Indiegogo before expanding to online retailers such as Amazon, among others. “Supporting this vision is our first crowdfunding campaign launched as a combined entity on Kickstarter, the MasterSous, an 8-in-1 Smart Cooker. We are already extremely pleased with the robust interest in this product, which has already exceeded our pledged goal by more than 300%. During the quarter, we also announced our accretive acquisition of Cloud b, Inc., the world’s leading manufacturer of products and accessories that help parents and children sleep better. With products distributed in over 100 countries worldwide, we have the unique ability to integrate our proprietary product development expertise to manufacture and market Cloud b’s existing products, while also helping to develop exciting new product lines. Their team of professionals and superior products will add a key element to our growth strategy, while expanding our footprint on the West coast by leveraging Cloud b’s significant distribution, sales and fulfillment operations.” Ferguson, concluded: “Our efforts to become a leading vertically integrated innovation aggregation and full-service product development and manufacturing company is unfolding quickly. As we move through the remainder of 2018 and into the new year, we look forward to continuing our operational and financial execution, which we are confident will drive shareholder value over the long-term.” Third Quarter 2018 Financial Results Revenue in the third quarter of 2018 increased 56% to $4.9 million, compared to $3.2 million in the third quarter of 2017. The increase in revenues was primarily due to the addition of new products and customers in the consumer products segment, as well as increased demand from customers in the packaging materials business. Gross profit increased 26% to $1.3 million in the third quarter of 2018, compared to $1.0 million in the third quarter of 2017. Gross profit margin as a percentage of revenue was 26.4% in the third quarter of 2018, compared to 32.5% in the third quarter of 2017. The decrease in gross profit margin as a percentage of revenues was primarily due to unfavorable product mix in the packaging materials business, as well as increased tariffs and lower margin product sales. Operating expenses were $2.1 million in the third quarter of 2018, compared to $0.8 million in the third quarter of 2017. The increase was primarily attributable to the increase in total segment and consolidated revenues. Net loss totaled $1.7 million, or ($0.37) per basic and diluted share in the third quarter of 2018, compared to net income of $0.3 million, or $0.11 per basic and diluted share in the third quarter of 2017. Adjusted EBITDA, a non-GAAP measure, totaled $37,000 in the third quarter of 2018, compared to $0.3 million in the third quarter of 2017. See below under the heading, “Use of Non-GAAP Financial Information” for a discussion of Adjusted EBITDA and a reconciliation of such measure to the most comparable measure calculated under U.S. generally accepted accounting principles ("GAAP"). Cash and cash equivalents at September 30, 2018 totaled $2.1 million, as compared to $3.9 million at June 30, 2018. The Company believes it currently has sufficient funds to meet its working capital, debt service and capital expenditure requirements for at least the next 12 months. Further details about Edison Nation’s results in the third quarter of 2018 are available in its Quarterly Report on Form 10-Q, accessible in the investor relations section of the Company’s website at www.edisonnation.com and through the U.S. Securities and Exchange Commission’s website. Edison Nation’s Crowdfunding Approach Edison Nation’s Crowdfunding tool was introduced to drive higher success potential for ideas to be commercialized. Investors submit their ideas through the Edison Nation platform (located on its website www.edisonnation.com), and for all ideas chosen from the Crowdfunding search, Edison Nation will handle the costs to develop the products and run their respective crowdfunding campaigns. Successful campaigns will provide a stronger position for products to be commercialized, either directly by Edison Nation, or through traditional licensing agreements. Edison Nation’s proprietary platform ensures privacy of intellectual property and streamlines communication and negotiations with innovators. For over 10 years, Edison Nation has been and continues to be the trusted destination for innovators, partners and consumers alike and the trusted leader for quality innovation. Market Outlook Consumer Buying Habits are Shifting The “retail apocalypse” is continuing as consumer purchasing habits trend towards online purchases. The e-commerce market is expected to grow at a 13% CAGR to $682B by 2020. Consumers are increasingly innovation driven with a need for instant gratification, as consumer desire for next-generation products surpasses the need for brand recognition. The trend towards crowd funding (i.e. Kickstarter)is disrupting the legacy product development cycle through pre-ordering of products – financing product development while reducing sales risk. Shifting consumer trends driving the growth of market places (i.e. Amazon) and crowd funding sites provide unique tailwinds for EDNT's growth. Technical Analysis Based on our most recent charting analysis of EDNT we see the potential for a run up to $9.00. This equates to a gain of up to +44% from today's alert price. As most of you know, we love low-float picks like EDNT because of their potential for huge single-session gains. EDNT is looking extremely attractive at our alert price of $6.25. We've watched EDNT swing between $5 and $7 several times over the past few weeks, which is why we believe a single-day move of over +20% is very possible. In fact, the last time we brought it to your attention shares ran-up over +20%! Traders who start their positions at our alert price could see themselves in the perfect low-risk/high-reward scenario. EDNT hasn't closed under $5.74 this entire month. EDNT has traded as high as $7.83, but we believe we could see an all new 52-week high in the immediate future! EDNT has the potential to be one of the biggest gainers on the Nasdaq. As such, we are urging all members to act fast, start their research, and make sure to add EDNT to the top of their watchlist (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by World Wide Holdings dba Invictus Resources LLC. to conduct investor relations advertising and marketing for EDNT. We have been previously compensated ten thousand dollars by World Wide Holdings dba Invictus Resources LLC. to conduct investor relations advertising and marketing for EDNT -which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. Top Market Gainers MJ Capital, LLC | PennyStockLocks, LLC PO Box 110226 Nutley, NJ 07110
ELong
by RedHotStocks
[LTC-USD]DESCENDING CHANNEL-BREAKOUT IMMINENT! BUY ZONE NEAR!Like I said on my video, I've looked at all the 4 hr charts for BTC, BCH, ETH & LTC. LTC is the most promising to me as a trader in the next 3 days or so. Big breakout coming! Nice profits imminent! Watch BTC carefully. BTC as of the post of this video is about 9102, if that dives, so will LTC , which means it will arrive at my targets of 142 or so, give or take. ITs a range. No one can predict exact numbers here. I hope all you cowboys understand that! So in the interim of the next 3-5 days, for now traders will short and then they will most likely go long! If you learned even just one thing then, please hit the like and follow me and follow this chart. When I open my position, you will see how I trade and profit> If I get 20 likes I will update. Show your support, these TA 's are for you not for me. So its SUPER IMPORTANT you show your support. I want to hit 300 followers in the next few days. I can only accomplish that with your support. PS: This is not financial advise , this is for educational purposes! Perform your own TA and perform your own risk management. Thanks , BIG HUG! CryptoBuzzAnalyst
BITFINEX:LTCUSDShort
by CryptoBuzzAnalyst
XLMUSD Reverse Head and Shoulders with 15% UpsideXLMUSD Lumen A small reverse head and shoulders with about 15% of upside to a minimum target at 508 once 445 is re-taken and held with stops below the neck-line when broken. It should then rally to the upper parallel where can look to take profits once this triggers. Until then this is still vulnerable to further sell offs - but slowly resistance looks to be getting ground away and eventually this is looking likely to pop to the upside again. Should be worth following when it does. But not until, unless it flips back down to the lower parallel first, which at this point looks unlikely.
BITTREX:XLMUSDLong
by sumastardon
WTI: US OIL Minimum Upside Target at 86.33WTI Crude Oil Minimum Medium Term Upside Target at 86.33 The Saudis are reported to need oil at $84 to balance their budget. By happy coincidence for them the minimum upside target created by the reverse head and shoulders is 86.33. In the nearer term WTI is flipping in a 300 pip range with support off the last highs at 66.48 and resistance at 69.48. It has to break below here by 10 pips or more to trigger further near term weakness and a short back to the 63.76 line where it should reverse higher again. Returning to the upside although WTI is likely to move sideways for a while longer as it unwinds the last 800 pip rally, whilst it holds up at 66.48 the trend remains positive overall. Once it breaks above 69.55 it should rally further to 71.14 and then, after consolidating some more at that point, to 75.28 and eventually to 86.33, the minimum target created by the RHS.
TVC:USOILLong
by sumastardon
SPX: S&P 500 Index Minimum Upside Target at 2794 S&P 500 Index Update Minimum Upside Target 2794 The next long signal here was the break above the key 2675-2673 line which ideally needed to be followed by a successful retest from above after the break occurred. We got that yesterday/overnight. Today's strength in AlphaBet as much as anything has helped the S&P gap up on the open and since then it's never looked back. It should rally to 2711 here and then start to consolidate gains before rallying further to 2740. Then after another period of consolidation it should go on to hit the 2800-2810 range before falling away back to 2740 once more. Major resistance at 2675-3 has with one bound become major support. Whilst above here the trend is back to positive after a thorough but successful test. There is also a clear reverse head and shoulders within the triangle formation for those who like pattern spotting with a minimum upside target at 2794.
SP:SPXLong
by sumastardon
LTC/BTC Possible Breakout DayAs we head into the weekend, have a gut feeling that we'll see some nice gains on Friday. Earlier in the week, discussed pivot point when we were in the middle of the downtrend channel (Pink Lines). It ended up retracing near the bottom around 150 mark. Today, we are sitting around 161, and on Monday 8 am (Black Vertical Line)EST the US market took over in the 182 range and drove the price down throughout the week. Expect Wall Street, Chicago, and whales will try to buy up the lower cost coins today to take advantage of the favorable pricing. On the 1 hr, we're sitting at the end point of a triangle, and just have a gut feeling we'll see a bounce. How high? Who knows. Also had some good news over the past day. Lightning Network news came out on Thursday. This should bode well for Litecoin and Bitcoin. Additionally, ARBA announced the creation of a new smart contract platform, and they will be using Litecoin and Bitcoin on their platform. Well, there you have it. Before I could type this idea, price shot up from 161 to 167. Hopefully this is an Elliot Wave run to the top of the channel. Good luck trading to all. As always, this is only an opinion and not considered to be investment advice. Trade at your own risk.
COINBASE:LTCUSDLong
by GeorgeChart